Fundamentals of Population Pharmacokinetic Modelling: Modelling and SoftwareKIANG, Tony K. L; SHERWIN, Catherine M. T; SPIGARELLI, Michael G et al.Clinical pharmacokinetics. 2012, Vol 51, Num 8, pp 515-525, issn 0312-5963, 11 p.Article

Population Pharmacokinetic Analysis during the First 2 Years of Life: An OverviewMARSOT, Amélie; BOULAMERY, Audrey; BRUGUEROLLE, Bernard et al.Clinical pharmacokinetics. 2012, Vol 51, Num 12, pp 787-798, issn 0312-5963, 12 p.Article

Some considerations on the design of population pharmacokinetic studiesDUFFULL, Stephen; WATERHOUSE, Tim; ECCLESTON, John et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 441-457, issn 1567-567X, 17 p.Article

Understanding the time course of pharmacological effect: a PKPD approachWRIGHT, Daniel F. B; WINTER, Helen R; DUFFULL, Stephen B et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 815-823, issn 0306-5251, 9 p.Article

Population pharmacokinetic model of PI-88, a heparanase inhibitorHUDACHEK, Susan F; ECKHARDT, S. Gail; HICKS, Barbara et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 743-753, issn 0344-5704, 11 p.Article

Population Pharmacokinetics of Therapeutic Monoclonal AntibodiesDIRKS, Nathanael L; MEIBOHM, Bernd.Clinical pharmacokinetics. 2010, Vol 49, Num 10, pp 633-659, issn 0312-5963, 27 p.Article

Reporting a Population Pharmacokinetic-Pharmacodynamic Study: A Journal's PerspectiveJAMSEN, Kris M; McLEAY, Sarah C; BARRAS, Michael A et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 111-122, issn 0312-5963, 12 p.Article

The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analysesVRIJENS, Bernard; GROSS, Robert; URQUHART, John et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 225-227, issn 1742-7835, 3 p.Article

Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy IndividualsAREBERG, Johan; PETERSEN, Kamilla B; CHEN, Grace et al.Basic & clinical pharmacology & toxicology (Print). 2014, Vol 115, Num 6, pp 552-559, issn 1742-7835, 8 p.Article

Fundamentals of Population Pharmacokinetic Modelling: Validation MethodsSHERWIN, Catherine M. T; KIANG, Tony K. L; SPIGARELLI, Michael G et al.Clinical pharmacokinetics. 2012, Vol 51, Num 9, pp 573-590, issn 0312-5963, 18 p.Article

Methods to Account for Inaccuracies in the Dosing History When Performing Population Pharmacokinetic AnalysisPAVAN KUMAR, Venkata V; DUFFULL, Stephen B.Pharmaceutical research. 2008, Vol 25, Num 12, pp 2740-2749, issn 0724-8741, 10 p.Article

Population pharmacokinetics of troxacitabine, a novel dioxolane nucleoside analogueLEE, Carlton K. K; ROWINSKY, Eric K; JING LI et al.Clinical cancer research. 2006, Vol 12, Num 7, pp 2158-2165, issn 1078-0432, 8 p., 1Article

Discrepancies in pharmacokinetic analysis results obtained by using two standard population pharmacokinetics software programsFINKELSTEIN, Yaron; NAVA-DCAMPO, Alejandro A; SCHECHTER, Tal et al.Fundamental & clinical pharmacology. 2009, Vol 23, Num 1, pp 53-57, issn 0767-3981, 5 p.Article

Dealing with time-dependent pharmacokinetics during the early clinical development of a new leukotriene B₄ synthesis inhibitorTROCONIZ, Inaki F; ZSOLT, Ilonka; GARRIDO, Maria J et al.Pharmaceutical research. 2006, Vol 23, Num 7, pp 1533-1542, issn 0724-8741, 10 p.Article

Population pharmacokinetics of mycophenolic acid during the first week after renal transplantationSTAATZ, Christine E; DUFFULL, Stephen B; KIBERD, Bryce et al.European journal of clinical pharmacology. 2005, Vol 61, Num 7, pp 507-516, issn 0031-6970, 10 p.Article

Telavancin Penetration into Human Epithelial Lining Fluid Determined by Population Pharmacokinetic Modeling and Monte Carlo SimulationLODISE, Thomas P; GOTFRIED, Mark; BARRIERE, Steven et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 7, pp 2300-2304, issn 0066-4804, 5 p.Article

Population pharmacokinetics. III: Design, analysis, and application of population pharmacokinetic studiesETTE, Ene I; WILLIAMS, Paul J; LANE, James R et al.The Annals of pharmacotherapy. 2004, Vol 38, Num 12, pp 2136-2144, issn 1060-0280, 9 p.Article

Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysisWÄHLBY, Ulrika; THOMSON, Alison H; MILLIGAN, Peter A et al.British journal of clinical pharmacology. 2004, Vol 58, Num 4, pp 367-377, issn 0306-5251, 11 p.Article

Performance of Different Population Pharmacokinetic AlgorithmsCOLUCCI, Philippe; GRENIER, Julie; SENG YUE, Corinne et al.Therapeutic drug monitoring. 2011, Vol 33, Num 5, pp 583-591, issn 0163-4356, 9 p.Article

Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokersCRONENBERGER, Carol; MOULD, Diane R; ROETHIG, Hans-Juergen et al.British journal of clinical pharmacology. 2008, Vol 65, Num 1, pp 30-39, issn 0306-5251, 10 p.Article

Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjectsLODISE, Thomas P; PYPSTRA, Rienk; KAHN, James B et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2378-2387, issn 0066-4804, 10 p.Article

Population approaches in paediatricsCHATELUT, Etienne.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 575-578, issn 0767-3981, 4 p.Conference Paper

Population Pharmacokinetics of Rifapentine and Desacetyl Rifapentine in Healthy Volunteers: Nonlinearities in Clearance and BioavailabilitySAVIC, Radojka M; YANHUI LU; BLIVEN-SIZEMORE, Erin et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 6, pp 3035-3042, issn 0066-4804, 8 p.Article

Influence of Erroneous Patient Records on Population Pharmacokinetic Modeling and Individual Bayesian EstimationDER MEER, Aize Franciscus Van; TOUW, Daniël J; MARCUS, Marco A. E et al.Therapeutic drug monitoring. 2012, Vol 34, Num 5, pp 526-534, issn 0163-4356, 9 p.Article

Interpreting population pharmacokinetic-pharmacodynamic analyses -a clinical viewpointDUFFULL, Stephen B; WRIGHT, Daniel F. B; WINTER, Helen R et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 807-814, issn 0306-5251, 8 p.Article